Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

CTMXCTMX
Showing 8 of 19 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in CYTOMX THERAPEUTICS INC.

Qube Research & Technologies Ltd holds 1.8M shares of CTMX (CYTOMX THERAPEUTICS INC.), worth $6.8M as of 2026-Q2. The position was decreased (-18.9% shares). CTMX represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$6.8M

Current Shares

1.8M

Total Value Change

+$6.8M

Total Shares Change

+1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.8M
-18.9%
$6.8M0.0%$3.75
0
2026-Q1
Increased
2.2M
+112.0%
$10.6M0.0%$4.81
45
2025-Q4
Increased
1.1M
+766.2%
$4.5M0.0%$4.16
43
2025-Q3
New
122,500
-
$390,7750.0%$3.23
33
2025-Q2
Exited
0
-100.0%
$00.0%$2.25
0
2025-Q1
Decreased
54,808
-0.5%
$34,8470.0%$0.63
0
2024-Q4
Unchanged
55,108
0.0%
$56,7610.0%$1.02
0
2024-Q3
Increased
55,108
+0.9%
$65,0270.0%$1.20
21

Other major holders of CTMX: FMR LLC, BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used